Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

enGene Therapeutics Inc. Common Stock

ENGN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ENGN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ENGN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ENGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ENGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ENGN holdings by institutional investors

Quarterly net insider trading by ENGN's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ENGN

Quiver Logo

No former government officials on record as having lobbied for ENGN

Revolving Door Dashboard

ENGN Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ENGN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ENGN Income Statement
ENGN Balance Sheet
ENGN Cash Flow
U.S. Patents

New ENGN patent grants

  • Patent Title: Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo Sep. 03, 2024
  • Patent Title: Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo Apr. 11, 2023
  • Patent Title: High concentration chitosan-nucleic acid polyplex compositions May. 12, 2020
  • Patent Title: High concentration chitosan-nucleic acid polyplex compositions Dec. 26, 2017
  • Patent Title: Dually derivatized chitosan nanoparticles and methods of making and using the same Apr. 18, 2017
  • Patent Title: Chitosan-based non-viral methods for transfecting gut cells in vivo Aug. 02, 2016
  • Patent Title: Non-viral compositions and methods for transfecting gut cells in vivo Sep. 30, 2014
  • Patent Title: High concentration chitosan-nucleic acid polyplex compositions May. 13, 2014
  • Patent Title: Chitosan based polymer conjugate and a method for producing the same Apr. 30, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ENGN from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ENGN News

Recent insights relating to ENGN

CNBC Recommendations

Recent picks made for ENGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ENGN

ENGN Analyst Ratings

ENGN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ENGN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ENGN stock a Buy, Sell, or Hold?

  • What is the price target for $ENGN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ENGN Top Shareholders
Shareholder
Shares Held
ENGN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ENGN stock?

  • Who owns the most shares of $ENGN stock?

  • What funds own $ENGN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ENGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ENGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ENGN

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.

enGene Therapeutics Inc. Common Stock (ENGN) Historical Stock Prices

enGene Therapeutics Inc. Common Stock (ENGN) closed at $1.96 on September 25, 2026. Over the past year its adjusted close ranged from $1.44 to $12.17. Daily prices go back to February 1, 2022, 969 trading days in all.

  • 1 month+0.51%
  • 3 months+12.00%
  • Year to date-78.29%
  • 1 year-69.85%
  • 3 years-82.12%
  • 5 years—
  • Max-80.12%
See every congressional and insider trade on the ENGN price chart

Quiver Premium charts ENGN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 1.94 1.97 1.88 1.96 1.96 1,976,168
Sep 24, 2026 1.99 1.99 1.91 1.92 1.92 796,304
Sep 23, 2026 2.05 2.05 1.98 2.00 2.00 669,455
Sep 22, 2026 1.96 2.08 1.96 2.05 2.05 1,066,302
Sep 21, 2026 1.92 1.97 1.90 1.96 1.96 426,339
Sep 18, 2026 1.92 1.93 1.89 1.91 1.91 400,979
Sep 17, 2026 1.90 1.92 1.88 1.91 1.91 637,548
Sep 16, 2026 1.90 1.92 1.88 1.91 1.91 579,256
Sep 15, 2026 1.87 1.90 1.84 1.89 1.89 618,745
Sep 14, 2026 1.80 1.88 1.80 1.87 1.87 460,523
Sep 11, 2026 1.80 1.83 1.79 1.80 1.80 651,007
Sep 10, 2026 1.85 1.85 1.76 1.77 1.77 565,327
Sep 9, 2026 1.89 1.92 1.84 1.85 1.85 486,375
Sep 8, 2026 1.82 1.94 1.78 1.92 1.92 1,508,314
Sep 4, 2026 1.82 1.83 1.78 1.82 1.82 412,684
Sep 3, 2026 1.90 1.91 1.80 1.83 1.83 634,651
Sep 2, 2026 1.84 1.92 1.83 1.89 1.89 1,061,722
Sep 1, 2026 1.84 1.87 1.80 1.85 1.85 657,377
Aug 31, 2026 1.83 1.85 1.81 1.84 1.84 291,275
Aug 28, 2026 1.91 1.91 1.81 1.82 1.82 447,136
Aug 27, 2026 1.94 1.94 1.91 1.91 1.91 252,118
Aug 26, 2026 1.87 1.95 1.87 1.95 1.95 1,831,085
Aug 25, 2026 1.82 1.89 1.81 1.87 1.87 1,006,357
Aug 24, 2026 1.79 1.83 1.75 1.81 1.81 642,503
Aug 21, 2026 1.79 1.80 1.77 1.78 1.78 242,727
Aug 20, 2026 1.84 1.85 1.75 1.77 1.77 368,436
Aug 19, 2026 1.73 1.90 1.73 1.85 1.85 1,263,362
Aug 18, 2026 1.70 1.74 1.69 1.72 1.72 690,939
Aug 17, 2026 1.72 1.73 1.69 1.70 1.70 623,324
Aug 14, 2026 1.69 1.73 1.66 1.70 1.70 919,724
Aug 13, 2026 1.71 1.73 1.68 1.69 1.69 470,129
Aug 12, 2026 1.82 1.83 1.69 1.70 1.70 1,670,501
Aug 11, 2026 1.76 1.82 1.73 1.82 1.82 1,446,100
Aug 10, 2026 1.78 1.78 1.74 1.75 1.75 464,138
Aug 7, 2026 1.81 1.84 1.78 1.80 1.80 351,626
Aug 6, 2026 1.80 1.81 1.77 1.80 1.80 303,982
Aug 5, 2026 1.81 1.81 1.76 1.80 1.80 156,071
Aug 4, 2026 1.78 1.82 1.77 1.79 1.79 640,751
Aug 3, 2026 1.79 1.80 1.73 1.77 1.77 525,500
Jul 31, 2026 1.78 1.80 1.71 1.79 1.79 306,255
Jul 30, 2026 1.81 1.82 1.74 1.76 1.76 731,177
Jul 29, 2026 1.73 1.86 1.71 1.79 1.79 560,027
Jul 28, 2026 1.76 1.77 1.72 1.76 1.76 582,867
Jul 27, 2026 1.85 1.89 1.75 1.76 1.76 651,327
Jul 24, 2026 1.89 1.89 1.81 1.82 1.82 665,841
Jul 23, 2026 1.83 1.93 1.80 1.89 1.89 1,659,521
Jul 22, 2026 1.93 1.94 1.82 1.85 1.85 555,287
Jul 21, 2026 1.87 1.94 1.86 1.93 1.93 259,892
Jul 20, 2026 1.83 1.89 1.82 1.87 1.87 759,298
Jul 17, 2026 1.89 1.95 1.82 1.82 1.82 798,871
Jul 16, 2026 1.89 1.94 1.85 1.92 1.92 756,761
Jul 15, 2026 1.88 1.96 1.82 1.90 1.90 813,162
Jul 14, 2026 1.88 1.93 1.85 1.90 1.90 1,351,249
Jul 13, 2026 1.89 1.89 1.83 1.86 1.86 1,049,317
Jul 10, 2026 1.92 1.93 1.85 1.90 1.90 1,096,344
Jul 9, 2026 1.86 1.93 1.85 1.92 1.92 1,360,161
Jul 8, 2026 1.87 1.95 1.84 1.86 1.86 1,521,143
Jul 7, 2026 1.91 1.96 1.86 1.92 1.92 1,409,129
Jul 6, 2026 1.79 1.95 1.78 1.91 1.91 2,866,895
Jul 2, 2026 1.79 1.81 1.75 1.78 1.78 588,354
Jul 1, 2026 1.74 1.78 1.73 1.76 1.76 605,237
Jun 30, 2026 1.79 1.87 1.73 1.73 1.73 1,109,061
Jun 29, 2026 1.73 1.80 1.72 1.78 1.78 1,030,003
Jun 26, 2026 1.76 1.82 1.74 1.75 1.75 1,242,405
Jun 25, 2026 1.76 1.81 1.72 1.77 1.77 1,668,850
Jun 24, 2026 1.71 1.83 1.70 1.75 1.75 1,476,887
Jun 23, 2026 1.68 1.73 1.68 1.71 1.71 547,323
Jun 22, 2026 1.74 1.76 1.69 1.69 1.69 883,240
Jun 18, 2026 1.75 1.81 1.70 1.72 1.72 885,200
Jun 17, 2026 1.75 1.79 1.72 1.74 1.74 1,305,746
Jun 16, 2026 1.74 1.76 1.70 1.75 1.75 1,216,351
Jun 15, 2026 1.75 1.82 1.73 1.77 1.77 2,157,978
Jun 12, 2026 1.63 1.67 1.62 1.62 1.62 458,509
Jun 11, 2026 1.61 1.65 1.57 1.64 1.64 492,995
Jun 10, 2026 1.67 1.69 1.57 1.60 1.60 976,740
Jun 9, 2026 1.67 1.69 1.60 1.67 1.67 495,081
Jun 8, 2026 1.66 1.69 1.63 1.65 1.65 614,437
Jun 5, 2026 1.71 1.74 1.61 1.64 1.64 954,398
Jun 4, 2026 1.69 1.77 1.69 1.72 1.72 644,832
Jun 3, 2026 1.73 1.73 1.66 1.67 1.67 812,625
Jun 2, 2026 1.77 1.79 1.71 1.74 1.74 937,460
Jun 1, 2026 1.84 1.85 1.76 1.78 1.78 995,259
May 29, 2026 1.77 1.87 1.75 1.85 1.85 1,108,408
May 28, 2026 1.72 1.78 1.70 1.78 1.78 700,477
May 27, 2026 1.76 1.76 1.69 1.72 1.72 1,242,357
May 26, 2026 1.70 1.79 1.64 1.76 1.76 1,969,391
May 22, 2026 1.73 1.76 1.64 1.64 1.64 1,267,377
May 21, 2026 1.60 1.76 1.60 1.73 1.73 1,767,195
May 20, 2026 1.53 1.63 1.53 1.61 1.61 2,000,938
May 19, 2026 1.56 1.59 1.50 1.53 1.53 1,424,594
May 18, 2026 1.70 1.73 1.54 1.57 1.57 1,834,997
May 15, 2026 1.75 1.76 1.62 1.72 1.72 2,750,157
May 14, 2026 1.54 1.82 1.53 1.81 1.81 6,941,912
May 13, 2026 1.44 1.60 1.44 1.54 1.54 2,503,089
May 12, 2026 1.45 1.50 1.40 1.44 1.44 4,347,714
May 11, 2026 1.51 1.58 1.45 1.49 1.49 5,659,507
May 8, 2026 1.71 1.75 1.45 1.50 1.50 17,386,929
May 7, 2026 2.15 2.24 1.70 1.72 1.72 24,102,681
May 6, 2026 7.95 9.00 7.95 8.85 8.85 388,695
May 5, 2026 7.72 8.03 7.49 7.89 7.89 426,270
May 4, 2026 7.19 7.76 7.19 7.61 7.61 388,584
May 1, 2026 7.30 7.45 7.13 7.25 7.25 236,028
Apr 30, 2026 7.05 7.36 7.00 7.27 7.27 155,174
Apr 29, 2026 6.93 7.25 6.86 7.04 7.04 344,624
Apr 28, 2026 7.18 7.59 6.82 6.96 6.96 1,780,310
Apr 27, 2026 7.99 8.06 7.14 7.20 7.20 846,041
Apr 24, 2026 8.02 8.34 7.69 7.99 7.99 222,241
Apr 23, 2026 8.40 8.85 8.03 8.14 8.14 450,000
Apr 22, 2026 8.57 8.67 8.25 8.54 8.54 340,973
Apr 21, 2026 8.58 8.65 8.29 8.51 8.51 173,553
Apr 20, 2026 8.05 8.53 7.66 8.53 8.53 395,742
Apr 17, 2026 8.18 8.46 7.82 8.07 8.07 842,967
Apr 16, 2026 7.87 8.15 7.47 8.08 8.08 285,473
Apr 15, 2026 7.62 7.76 7.31 7.76 7.76 211,274
Apr 14, 2026 7.47 7.73 7.39 7.60 7.60 140,825
Apr 13, 2026 7.25 7.64 7.11 7.43 7.43 210,061
Apr 10, 2026 7.31 7.42 7.10 7.20 7.20 95,288
Apr 9, 2026 7.24 7.37 7.07 7.27 7.27 186,018
Apr 8, 2026 7.66 7.71 7.01 7.31 7.31 117,705
Apr 7, 2026 7.19 7.70 7.08 7.33 7.33 357,799
Apr 6, 2026 6.69 7.30 6.69 7.24 7.24 218,198
Apr 2, 2026 6.61 6.89 6.53 6.69 6.69 332,808
Apr 1, 2026 6.93 7.11 6.64 6.76 6.76 143,400
Mar 31, 2026 6.29 6.98 6.29 6.81 6.81 244,164
Mar 30, 2026 6.36 6.54 6.05 6.18 6.18 140,103
Mar 27, 2026 6.92 7.06 6.22 6.37 6.37 162,386
Mar 26, 2026 6.90 7.30 6.84 6.96 6.96 115,571
Mar 25, 2026 6.94 7.30 6.94 7.07 7.07 114,313
Mar 24, 2026 7.20 7.33 6.71 6.90 6.90 145,689
Mar 23, 2026 7.22 7.50 6.92 7.31 7.31 143,255
Mar 20, 2026 7.19 7.48 7.10 7.21 7.21 193,064
Mar 19, 2026 7.04 7.24 6.95 7.21 7.21 149,494
Mar 18, 2026 7.10 7.47 6.91 7.18 7.18 1,084,742
Mar 17, 2026 7.27 7.92 7.24 7.25 7.25 516,620
Mar 16, 2026 7.28 7.54 6.99 7.23 7.23 372,095
Mar 13, 2026 7.38 7.43 6.94 7.16 7.16 791,266
Mar 12, 2026 6.86 7.80 6.60 7.30 7.30 1,569,496
Mar 11, 2026 6.83 7.13 6.67 6.88 6.88 819,794
Mar 10, 2026 6.98 7.42 6.78 6.94 6.94 3,128,221
Mar 9, 2026 8.06 8.39 6.86 7.05 7.05 1,418,853
Mar 6, 2026 8.53 8.95 8.44 8.68 8.68 165,337
Mar 5, 2026 9.65 9.72 8.70 8.71 8.71 637,842
Mar 4, 2026 9.83 10.09 9.71 9.74 9.74 161,883
Mar 3, 2026 9.85 9.99 9.27 9.66 9.66 344,071
Mar 2, 2026 9.71 10.34 9.71 10.00 10.00 94,137
Feb 27, 2026 10.01 10.24 9.95 10.11 10.11 58,426
Feb 26, 2026 10.09 10.24 9.89 10.03 10.03 96,810
Feb 25, 2026 9.89 10.28 9.78 10.10 10.10 126,685
Feb 24, 2026 9.79 10.10 9.58 9.78 9.78 337,581
Feb 23, 2026 10.36 10.65 9.60 9.67 9.67 191,812
Feb 20, 2026 10.43 10.49 10.18 10.36 10.36 85,384
Feb 19, 2026 10.02 10.69 9.96 10.62 10.62 190,253
Feb 18, 2026 9.89 10.17 9.73 10.06 10.06 98,304
Feb 17, 2026 9.77 9.96 9.49 9.89 9.89 110,754
Feb 13, 2026 9.93 10.00 9.64 9.78 9.78 136,819
Feb 12, 2026 9.88 10.16 9.79 9.94 9.94 181,278
Feb 11, 2026 9.66 10.20 9.30 9.92 9.92 195,700
Feb 10, 2026 9.71 10.12 9.50 9.53 9.53 230,339
Feb 9, 2026 9.36 9.81 9.24 9.74 9.74 130,303
Feb 6, 2026 8.95 9.78 8.95 9.55 9.55 417,110
Feb 5, 2026 9.58 9.79 8.76 8.86 8.86 1,159,792
Feb 4, 2026 10.00 10.67 8.86 9.59 9.59 362,581
Feb 3, 2026 10.00 10.48 9.84 9.97 9.97 224,450
Feb 2, 2026 9.55 10.46 9.53 10.00 10.00 295,157
Jan 30, 2026 10.94 11.38 9.51 9.53 9.53 302,542
Jan 29, 2026 10.13 10.44 9.78 10.27 10.27 137,553
Jan 28, 2026 11.14 11.20 9.81 10.20 10.20 334,351
Jan 27, 2026 11.26 11.61 10.96 11.11 11.11 184,409
Jan 26, 2026 12.02 12.21 11.32 11.40 11.40 573,012
Jan 23, 2026 10.55 12.25 10.49 12.17 12.17 1,835,723
Jan 22, 2026 9.50 10.88 9.34 10.64 10.64 1,097,837
Jan 21, 2026 9.10 9.63 9.01 9.34 9.34 651,295
Jan 20, 2026 9.12 9.60 8.68 9.10 9.10 603,551
Jan 16, 2026 9.22 9.55 9.10 9.31 9.31 262,756
Jan 15, 2026 9.30 9.47 8.77 9.22 9.22 467,162
Jan 14, 2026 8.43 9.23 8.30 9.10 9.10 694,009
Jan 13, 2026 8.30 8.67 8.30 8.38 8.38 131,084
Jan 12, 2026 8.69 8.71 8.16 8.30 8.30 199,795
Jan 9, 2026 8.54 9.20 8.39 8.81 8.81 446,058
Jan 8, 2026 8.47 8.73 8.08 8.50 8.50 89,405
Jan 7, 2026 8.36 9.04 8.30 8.50 8.50 188,394
Jan 6, 2026 8.67 8.87 8.17 8.26 8.26 200,775
Jan 5, 2026 8.90 8.93 8.40 8.73 8.73 112,613
Jan 2, 2026 9.09 9.10 8.44 8.85 8.85 127,435
Dec 31, 2025 9.16 9.16 8.62 9.03 9.03 103,187
Dec 30, 2025 9.07 9.24 8.90 8.95 8.95 88,925
Dec 29, 2025 9.48 9.81 9.04 9.04 9.04 412,324
Dec 26, 2025 9.55 9.69 9.36 9.50 9.39 438,780
Dec 24, 2025 9.29 10.10 9.17 9.45 9.45 583,997
Dec 23, 2025 8.77 9.77 8.68 9.22 9.22 367,614
Dec 22, 2025 8.72 8.95 8.46 8.77 8.77 84,618
Dec 19, 2025 8.19 8.89 7.89 8.69 8.69 206,829
Dec 18, 2025 7.57 8.28 7.57 8.17 8.17 278,789
Dec 17, 2025 8.45 8.47 7.69 7.80 7.80 272,741
Dec 16, 2025 8.35 8.45 8.10 8.38 8.38 143,359
Dec 15, 2025 8.48 8.70 8.05 8.43 8.43 168,578
Dec 12, 2025 8.91 9.14 8.20 8.46 8.46 316,280
Dec 11, 2025 8.04 8.99 7.75 8.92 8.79 242,261
Dec 10, 2025 8.23 8.29 7.75 8.01 8.01 185,278
Dec 9, 2025 8.35 8.49 7.95 8.23 8.23 749,198
Dec 8, 2025 8.10 8.39 7.77 8.36 8.36 240,679
Dec 5, 2025 8.27 8.27 7.84 8.07 7.98 188,902
Dec 4, 2025 8.00 8.24 7.96 8.22 8.22 190,828
Dec 3, 2025 7.67 8.05 7.65 8.00 8.00 230,158
Dec 2, 2025 7.98 8.29 7.73 7.86 7.86 175,336
Dec 1, 2025 7.84 8.12 7.55 7.91 7.91 297,987
Nov 28, 2025 8.34 8.36 7.92 8.07 8.07 398,589
Nov 26, 2025 7.64 8.30 7.60 8.25 8.25 284,450
Nov 25, 2025 7.36 7.85 7.36 7.71 7.79 534,857
Nov 24, 2025 6.90 7.59 6.84 7.41 7.41 470,725
Nov 21, 2025 6.60 7.26 6.55 6.96 6.96 717,679
Nov 20, 2025 6.85 7.06 6.49 6.60 6.50 538,886
Nov 19, 2025 6.98 7.20 6.31 6.76 6.76 1,749,729
Nov 18, 2025 8.00 8.27 6.76 6.88 7.26 926,934
Nov 17, 2025 8.47 8.65 8.03 8.06 8.27 930,104
Nov 14, 2025 8.32 9.20 8.32 8.53 8.70 1,201,843
Nov 13, 2025 9.25 9.29 8.14 8.43 8.43 2,608,590
Nov 12, 2025 9.69 9.80 8.62 8.68 8.82 2,196,574
Nov 11, 2025 8.55 11.14 7.83 8.82 9.17 51,454,331
Nov 10, 2025 6.11 6.23 5.85 6.01 6.01 85,526
Nov 7, 2025 5.96 6.09 5.72 6.06 5.85 212,817
Nov 6, 2025 6.31 6.39 5.95 6.02 5.50 228,368
Nov 5, 2025 6.59 6.81 6.29 6.34 6.43 84,348
Nov 4, 2025 6.81 7.25 6.34 6.53 6.69 716,255
Nov 3, 2025 7.21 7.49 6.52 6.92 6.92 196,655
Oct 31, 2025 6.96 7.40 6.86 7.21 7.21 115,302
Oct 30, 2025 7.35 7.68 6.58 6.96 6.96 242,693
Oct 29, 2025 7.90 8.39 7.13 7.33 7.33 81,991
Oct 28, 2025 7.89 8.18 7.78 7.91 7.91 80,038
Oct 27, 2025 8.40 8.83 7.80 7.96 7.96 68,013
Oct 24, 2025 7.94 8.61 7.75 8.27 8.27 104,444
Oct 23, 2025 8.04 8.42 7.70 7.87 7.87 80,298
Oct 22, 2025 8.50 8.73 7.61 8.10 8.10 259,567
Oct 21, 2025 9.02 9.65 8.44 8.50 8.69 697,516
Oct 20, 2025 9.00 9.59 9.00 9.33 9.33 307,798
Oct 17, 2025 8.67 9.59 8.51 9.35 9.35 527,437
Oct 16, 2025 8.49 9.29 8.49 8.80 8.80 298,123
Oct 15, 2025 8.90 9.01 8.36 8.80 8.80 309,838
Oct 14, 2025 8.19 9.00 8.00 8.81 8.81 769,831
Oct 13, 2025 8.47 8.80 8.00 8.29 8.29 283,230
Oct 10, 2025 8.85 8.85 8.00 8.39 8.39 365,417
Oct 9, 2025 7.57 8.96 7.47 8.89 8.47 1,991,262
Oct 8, 2025 7.21 7.49 6.98 7.41 7.41 569,011
Oct 7, 2025 7.69 7.81 6.56 7.01 7.01 197,463
Oct 6, 2025 7.68 7.81 7.19 7.60 7.60 72,780
Oct 3, 2025 8.28 8.28 7.51 7.75 7.66 80,465
Oct 2, 2025 7.68 8.35 7.60 8.14 8.14 304,666
Oct 1, 2025 6.83 7.62 6.71 7.60 7.60 237,789
Sep 30, 2025 6.55 6.84 6.46 6.83 6.83 69,956
Sep 29, 2025 6.57 6.57 6.10 6.45 6.45 28,524
Sep 26, 2025 6.44 6.66 6.07 6.49 6.49 39,786
Sep 25, 2025 7.00 7.00 6.24 6.50 6.50 43,833

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
enGene Therapeutics Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ENGN, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation